Ruth A. Fugmann

616 total citations
29 papers, 417 citations indexed

About

Ruth A. Fugmann is a scholar working on Oncology, Biotechnology and Immunology. According to data from OpenAlex, Ruth A. Fugmann has authored 29 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Biotechnology and 10 papers in Immunology. Recurrent topics in Ruth A. Fugmann's work include Cancer Research and Treatments (10 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ruth A. Fugmann is often cited by papers focused on Cancer Research and Treatments (10 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ruth A. Fugmann collaborates with scholars based in United States and Canada. Ruth A. Fugmann's co-authors include Daniel Martín, Daniel M. Shapiro, Robert L. Stolfi, James D. Fenters, Robert D. Gibbons, Maurice E. Shils, Catherine Aranyi, M. Michael Sigel, Morton M. Kligerman and Peter Thomas and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Journal of Virology.

In The Last Decade

Ruth A. Fugmann

26 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth A. Fugmann United States 14 148 82 82 81 58 29 417
Elliott H. Stonehill United States 8 110 0.7× 192 2.3× 42 0.5× 61 0.8× 36 0.6× 12 408
H. J. Tagnon Belgium 13 116 0.8× 104 1.3× 65 0.8× 20 0.2× 86 1.5× 38 491
Eiro Tsubura Japan 14 71 0.5× 193 2.4× 32 0.4× 99 1.2× 83 1.4× 54 493
Katsuhiro Imaki Japan 8 37 0.3× 105 1.3× 80 1.0× 101 1.2× 106 1.8× 12 438
W. Rapp Germany 13 36 0.2× 195 2.4× 35 0.4× 74 0.9× 63 1.1× 48 530
Angelo Dinota Italy 15 192 1.3× 216 2.6× 26 0.3× 178 2.2× 63 1.1× 40 545
Richard Faint United Kingdom 13 84 0.6× 193 2.4× 175 2.1× 61 0.8× 54 0.9× 17 556
Julie Wymer United States 9 221 1.5× 329 4.0× 132 1.6× 48 0.6× 93 1.6× 11 712
K Csóka Sweden 12 207 1.4× 246 3.0× 44 0.5× 37 0.5× 47 0.8× 19 503
T J Fraser United States 8 207 1.4× 424 5.2× 63 0.8× 31 0.4× 33 0.6× 9 686

Countries citing papers authored by Ruth A. Fugmann

Since Specialization
Citations

This map shows the geographic impact of Ruth A. Fugmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth A. Fugmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth A. Fugmann more than expected).

Fields of papers citing papers by Ruth A. Fugmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth A. Fugmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth A. Fugmann. The network helps show where Ruth A. Fugmann may publish in the future.

Co-authorship network of co-authors of Ruth A. Fugmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth A. Fugmann. A scholar is included among the top collaborators of Ruth A. Fugmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth A. Fugmann. Ruth A. Fugmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stock, Christiane, Daniel Martín, Kanematsu Sugiura, et al.. (1978). Antitumor tests of amygdalin in spontaneous animal tumor systems. Journal of Surgical Oncology. 10(2). 89–123. 16 indexed citations
2.
Stolfi, Robert L., et al.. (1977). Augmented therapeutic results elicited by splenectomy in combined modality treatment of spontaneous murine breast cancer. Cancer Immunology Immunotherapy. 3(2). 6 indexed citations
3.
Fugmann, Ruth A., et al.. (1977). Comparison of adjuvant chemotherapeutic activity against primary and metastatic spontaneous murine tumors.. PubMed. 37(2). 496–500. 31 indexed citations
4.
Martín, Daniel, Robert L. Stolfi, & Ruth A. Fugmann. (1977). Animal models for tumor immunotherapy ? A commentary. Cancer Immunology Immunotherapy. 2(1). 6 indexed citations
5.
Martín, Daniel, et al.. (1975). A solid tumor animal model predictive for human breast cancer. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 6 indexed citations
6.
Stolfi, Robert L., et al.. (1975). Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.. PubMed. 114(6). 1824–30. 10 indexed citations
7.
Fugmann, Ruth A., et al.. (1974). Rationale of combined modality therapy for cancer.. PubMed. 4(1). 13–24. 7 indexed citations
8.
Stolfi, Robert L., et al.. (1974). Synergism between host anti‐tumor immunity and combined modality therapy against murine breast cancer. International Journal of Cancer. 13(3). 389–403. 13 indexed citations
9.
Martín, Daniel, et al.. (1970). Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.. PubMed. 30(3). 709–16. 19 indexed citations
10.
Fugmann, Ruth A. & M. Michael Sigel. (1968). Immunologic and immunochemical studies in the hamster. I. The role of the antigen in eliciting IgG- and IgM-associated antibodies.. PubMed. 100(5). 1101–11. 3 indexed citations
11.
Sigel, M. Michael & Ruth A. Fugmann. (1968). Studies on immunoglobulins reactive with tumor cells and antigens.. PubMed. 28(7). 1457–9. 1 indexed citations
12.
Martín, Daniel, et al.. (1964). COMBINATION THERAPY WITH CYCLOPHOSPHAMIDE AND ZYMOSAN ON A SPONTANEOUS MAMMARY CANCER IN MICE.. PubMed. 24. 652–4. 20 indexed citations
13.
Martín, Daniel, et al.. (1962). Surgery, Cancer Chemotherapy, Host Defenses, and Tumor Size<xref ref-type="fn" rid="fn1">2</xref>. JNCI Journal of the National Cancer Institute. 36 indexed citations
14.
Martín, Daniel, L.S. Dietrich, & Ruth A. Fugmann. (1960). Hormonal Augmentation of Antimetabolite Chemotherapy.. Experimental Biology and Medicine. 103(1). 58–60. 3 indexed citations
15.
Kligerman, Morton M., et al.. (1958). Radiotherapy and adjuvant combination chemotherapy (6-aminonicotinamide and 6-mercaptopurine).. PubMed. 18(8 Part 1). 893–6. 16 indexed citations
16.
Shapiro, Daniel M., Ruth A. Fugmann, & L.S. Dietrich. (1957). Partial regression of a solid tumor with multi-compound chemotherapy.. PubMed. 17(11). 1067–70. 1 indexed citations
17.
Shapiro, Daniel M. & Ruth A. Fugmann. (1957). Combination Chemotherapy: Synergism between a Possible Folic Acid Antagonist and Ethionine on a “Solid” Tumor<xref ref-type="fn" rid="FN1">2</xref>. JNCI Journal of the National Cancer Institute. 3 indexed citations
18.
Shapiro, Daniel M. & Ruth A. Fugmann. (1957). A role for chemotherapy as an adjunct to surgery.. PubMed. 17(11). 1098–101. 69 indexed citations
19.
Shapiro, Daniel M., et al.. (1956). Quantitative Biochemical Differences between Tumor and Host as a Basis for Cancer Chemotherapy. Cancer Research. 16(7). 575–580. 18 indexed citations
20.
Shapiro, Daniel M. & Ruth A. Fugmann. (1952). Combination Chemotherapy of Cancer with 8-Azaguanine and a Riboflavin Analog.. Experimental Biology and Medicine. 81(1). 239–242. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026